RDY 398 (Lansoprazole delayed release 15 mg)
Pill imprint RDY 398 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 398
- Strength:
- 15 mg
- Color:
- Pink / Green
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0398
- Inactive Ingredients:
- ammonia
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
propylene glycol
shellac
corn starch
sucrose
raw sugar
titanium dioxide
magnesium silicate
gelatin
ferric oxide red
ferric oxide yellow
FD&C Blue No. 2
sodium lauryl sulfate
More about lansoprazole
Consumer resources
- Lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
- Other brands: Prevacid, Prevacid SoluTab, Prevacid OTC, Prevacid IV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
